IRIDEX Management

Management criteria checks 3/4

IRIDEX's CEO is Patrick Mercer, appointed in May 2024, has a tenure of less than a year. total yearly compensation is $518.07K, comprised of 64.9% salary and 35.1% bonuses, including company stock and options. directly owns 0.37% of the company’s shares, worth $112.34K. The average tenure of the management team and the board of directors is 0.7 years and 5.8 years respectively.

Key information

Patrick Mercer

Chief executive officer

US$518.1k

Total compensation

CEO salary percentage64.9%
CEO tenureless than a year
CEO ownership0.4%
Management average tenureless than a year
Board average tenure5.8yrs

Recent management updates

Recent updates

Revenues Working Against IRIDEX Corporation's (NASDAQ:IRIX) Share Price Following 26% Dive

Jun 11
Revenues Working Against IRIDEX Corporation's (NASDAQ:IRIX) Share Price Following 26% Dive

Is IRIDEX (NASDAQ:IRIX) In A Good Position To Invest In Growth?

May 14
Is IRIDEX (NASDAQ:IRIX) In A Good Position To Invest In Growth?

Iridex's Strategic Review Process Should Bear Fruit 'Soon'

Mar 28

Little Excitement Around IRIDEX Corporation's (NASDAQ:IRIX) Revenues

Feb 14
Little Excitement Around IRIDEX Corporation's (NASDAQ:IRIX) Revenues

Will IRIDEX (NASDAQ:IRIX) Spend Its Cash Wisely?

Oct 04
Will IRIDEX (NASDAQ:IRIX) Spend Its Cash Wisely?

Lacklustre Performance Is Driving IRIDEX Corporation's (NASDAQ:IRIX) 32% Price Drop

Aug 12
Lacklustre Performance Is Driving IRIDEX Corporation's (NASDAQ:IRIX) 32% Price Drop

Will IRIDEX (NASDAQ:IRIX) Spend Its Cash Wisely?

Apr 14
Will IRIDEX (NASDAQ:IRIX) Spend Its Cash Wisely?

We're Hopeful That IRIDEX (NASDAQ:IRIX) Will Use Its Cash Wisely

Oct 12
We're Hopeful That IRIDEX (NASDAQ:IRIX) Will Use Its Cash Wisely

Is IRIDEX (NASDAQ:IRIX) Using Too Much Debt?

Feb 25
Is IRIDEX (NASDAQ:IRIX) Using Too Much Debt?

Iridex To Benefit From New Revolutionary Glaucoma Treatment

Jan 11

Analysts Expect Breakeven For IRIDEX Corporation (NASDAQ:IRIX) Before Long

Jan 03
Analysts Expect Breakeven For IRIDEX Corporation (NASDAQ:IRIX) Before Long

IRIDEX says laser therapy now accepted in the European Glaucoma Society guidelines

Dec 23

CEO Compensation Analysis

How has Patrick Mercer's remuneration changed compared to IRIDEX's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 28 2024n/an/a

-US$11m

Jun 29 2024n/an/a

-US$11m

Mar 30 2024n/an/a

-US$11m

Dec 30 2023US$518kUS$336k

-US$10m

Sep 30 2023n/an/a

-US$8m

Jul 01 2023n/an/a

-US$8m

Apr 01 2023n/an/a

-US$7m

Dec 31 2022US$568kUS$317k

-US$8m

Oct 01 2022n/an/a

-US$9m

Jul 02 2022n/an/a

-US$9m

Apr 02 2022n/an/a

-US$6m

Jan 01 2022US$765kUS$317k

-US$5m

Oct 02 2021n/an/a

-US$3m

Jul 03 2021n/an/a

-US$3m

Apr 03 2021n/an/a

-US$7m

Jan 02 2021US$472kUS$316k

-US$6m

Sep 26 2020n/an/a

-US$8m

Jun 27 2020n/an/a

-US$8m

Mar 28 2020n/an/a

-US$7m

Dec 28 2019US$500kUS$277k

-US$9m

Compensation vs Market: Patrick's total compensation ($USD518.07K) is about average for companies of similar size in the US market ($USD649.07K).

Compensation vs Earnings: Patrick's compensation has been consistent with company performance over the past year.


CEO

Patrick Mercer (52 yo)

less than a year

Tenure

US$518,073

Compensation

Mr. Patrick Mercer is Chief Executive Officer of IRIDEX Corporation from October 1, 2024 and serves as it's President since May 22, 2024 and was its Chief Operating Officer since September 2018 until Octob...


Leadership Team

NamePositionTenureCompensationOwnership
Scott Shuda
Executive Chairman5.8yrsUS$154.00k0.41%
$ 125.9k
Patrick Mercer
CEO & Presidentless than a yearUS$518.07k0.37%
$ 112.3k
Fuad Ahmad
Interim Chief Financial Officer4.2yrsUS$356.84kno data
Leigh Salvo
Head of Investor Relationsno datano datano data

0.7yrs

Average Tenure

54yo

Average Age

Experienced Management: IRIX's management team is not considered experienced ( 0.7 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Scott Shuda
Executive Chairman5.8yrsUS$154.00k0.41%
$ 125.9k
Beverly Huss
Independent Director2.8yrsUS$127.50k0.17%
$ 50.3k
Kenneth Ludlum
Independent Director5.8yrsUS$134.50k0.38%
$ 114.3k
Robert Grove
Independent Director6.3yrsUS$119.00k0.73%
$ 221.1k

5.8yrs

Average Tenure

67yo

Average Age

Experienced Board: IRIX's board of directors are considered experienced (5.8 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 00:04
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/28
Annual Earnings2023/12/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

IRIDEX Corporation is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Scott HenryRoth MKM
Joseph MundaSidoti & Company, LLC
Lisa SpringerSingular Research